全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

公共产品赤字下政府应对策略研究——以中国政府应对HPV疫苗供应不足为例
Government Response Strategy under Public Product Deficit: A Case Study of Chinese Government Countermeasures to Insufficient Supply of HPV Vaccine

DOI: 10.12677/MM.2022.125076, PP. 571-577

Keywords: 公共产品,中国政府,HPV疫苗
Public Goods
, Chinese Government, HPV Vaccine

Full-Text   Cite this paper   Add to My Lib

Abstract:

公共产品具有非排他性和非竞争性两个基本特征,而全球公共产品则指的是在全球范围内流通的公共产品。近些年来,随着宫颈癌确诊人数的不断增加,中国政府越来越重视宫颈癌的预防。HPV疫苗是预防宫颈癌的重要手段,是一种纯公共产品。但是,由于近些年来美国霸权主义盛行、世界卫生组织话语权不强等原因,我国的HPV疫苗供应严重不足。本文主要是针对HPV疫苗供应不足的问题,来深入研究中国政府在面临公共产品供应不足时采取的措施,从而为解决相关的问题提供解决措施。
Public goods have two basic characteristics of non-exclusivity and non-competition, while global public goods refer to the public goods circulating in the global scope. In recent years, with the increasing number of cervical cancer diagnoses, the Chinese government has paid more attention to the prevention of cervical cancer. HPV vaccine is an important means to prevent cervical cancer and is a pure public good. However, due to the prevalence of hegemonism in the United States in recent years, the voice of the World Health Organization being not strong and other reasons, China’s HPV vaccine supply is seriously insufficient. This paper focuses on the insufficient supply of HPV vaccine to study the measures taken by the Chinese government in the face of insufficient supply of public goods, so as to provide solutions to the relevant problems.

References

[1]  Small Jr, W., Bacon, M.A., Bajaj, A., Chuang, L.T., Fisher, B.J., Harkenrider, M.M., Jhingran, A., Kitchener, H.C., Mileshkin, L.R., Viswanathan, A.N. and Gaffney, D.K. (2017) Cervical Cancer: A Global Health Crisis. Cancer, 123, 2404-2412.
https://doi.org/10.1002/cncr.30667
[2]  祎凡, 刘晓雪, 尹遵栋, 余文周, 曹雷, 曹玲生, 叶家楷, 李力, 吴静. 2018-2020年中国9-45岁女性人乳头瘤病毒疫苗估算接种率[J]. 中国疫苗和免疫, 2021, 27(5): 570-575.
https://doi.org/10.19914/j.CJVI.202110
[3]  李小毛, 李依芬, 万璟, 杨越波, 张宇. 青春前期女性接种人乳头瘤病毒疫苗专家共识[J]. 华南预防医学, 2021, 47(9): 1155-1161.
[4]  王艺如. 宫颈癌预防研究现状与HPV疫苗的研究进展[J]. 中国处方药, 2021, 19(8): 17-18.
[5]  Samuelson, P.A. (1954) Theory of Public Ex-penditure. The Review of Economics Statistics, 36, 387-389.
https://doi.org/10.2307/1925895
[6]  Olson, M. (1956) Logic of Collective Action: Public Goods and the Theory of Groups. Harvard University Press, Cambridge, 14.
[7]  张馨. “市场失效论”和“公共产品论”不成立吗——论市场经济下财政学的理论基础[J]. 财贸经济, 2021, 42(1): 16-25.
https://doi.org/10.19795/j.cnki.cn11-1166/f.20210107.003
[8]  [美]英吉?考尔. 全球化之道: 全球公共产品的提供与管理[M]. 张春波, 高静, 译. 北京: 人民出版社, 2006: 34.
[9]  王雪松, 刘金源. 全球公共产品视角下新冠肺炎疫苗供给困境、中国路径与挑战对策[J]. 当代世界与社会主义, 2021(1): 132-141.
[10]  田旭, 徐秀军. 全球公共产品赤字及中国应对实践[J]. 世界经济与政治, 2021(9): 128-154+159-160.
[11]  黄留叶. 宫颈癌可防可控, 中国HPV疫苗或将惠及非洲国家[J]. 国际人才交流, 2021(5): 48-50.
[12]  宫琦. 人乳头瘤病毒检查联合液基薄层细胞学检查在宫颈癌早期诊断中的效能[J]. 中国民康医学, 2022, 34(3): 115-117.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133